Surmodics, Inc.

Historical 13F Holders

Symbol
SRDX
CUSIP
868873100
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 868873100 since 12/18/2024, largest first.

Filer % of Class Filed
AllianceBernstein L.P. 13G/A 5.9% 5/14/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Beryl Capital Management LLC 13G/A
1.7% 2/13/2025
Event 12/31/2024
Gamco Investors, Inc. Et Al 13D/A
0% 11/20/2025
Event 11/19/2025
Soleus Capital Master Fund, L.P. 13G/A
0% 11/7/2025
Event 9/30/2025
Trium Capital LLP 13G/A 0% 11/20/2025
Event 11/19/2025
Barclays PLC 13G/A
Checked 5% or less
5/13/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 1 2.00 $83.00
2025 Q3 158 11.6 M $346 M
2025 Q2 145 12.4 M $367 M
2025 Q1 141 11.9 M $362 M
2024 Q4 144 12.0 M $476 M
2024 Q3 131 11.9 M $463 M
2024 Q2 130 14.4 M $605 M
2024 Q1 118 14.5 M $424 M
2023 Q4 123 14.4 M $522 M
2023 Q3 109 12.3 M $395 M
2023 Q2 109 12.3 M $385 M
2023 Q1 125 12.6 M $286 M
2022 Q4 128 13.4 M $456 M
2022 Q3 129 13.2 M $403 M
2022 Q2 131 12.8 M $477 M
2022 Q1 138 12.8 M $578 M
2021 Q4 151 12.6 M $608 M
2021 Q3 155 12.6 M $701 M
2021 Q2 151 12.5 M $677 M
2021 Q1 143 13.1 M $705 M
2020 Q4 146 12.7 M $557 M
2020 Q3 146 12.2 M $476 M
2020 Q2 137 12.2 M $528 M
2020 Q1 129 12.3 M $411 M
2019 Q4 149 12.4 M $513 M
2019 Q3 152 11.8 M $539 M
2019 Q2 151 12.3 M $531 M
2019 Q1 158 11.8 M $511 M
2018 Q4 170 11.9 M $565 M
2018 Q3 181 11.6 M $868 M
2018 Q2 149 11.5 M $633 M
2018 Q1 122 11.2 M $426 M
2017 Q4 117 11.1 M $311 M
2017 Q3 122 11.2 M $348 M
2017 Q2 119 11.3 M $317 M
2017 Q1 115 11.5 M $276 M
2016 Q4 120 11.4 M $290 M
2016 Q3 128 11.5 M $345 M
2016 Q2 120 11.2 M $263 M
2016 Q1 118 11.6 M $213 M
2015 Q4 123 11.5 M $233 M
2015 Q3 125 11.6 M $253 M
2015 Q2 120 11.6 M $271 M
2015 Q1 120 11.6 M $302 M
2014 Q4 114 11.5 M $254 M
2014 Q3 115 11.7 M $212 M
2014 Q2 114 11.8 M $253 M
2014 Q1 114 12.0 M $272 M